Previous studies have shown that REGO inhibits AKT phosphorylation in hepatocellular carcinoma and sarcoma and reduced PI3K and p-AKT expression of both HCC and neuroblastoma cells [40]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.